{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:58:38Z","timestamp":1757703518354,"version":"3.44.0"},"reference-count":28,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"unspecified","delay-in-days":6,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Ophth"],"accepted":{"date-parts":[[2023,10,15]]},"published-print":{"date-parts":[[2023,11]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The aim of this study was to assess the risk factors for atrophic progression of patients with papilloedema secondary to intracranial hypertension, using optical coherence tomography parameters.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>A retrospective study was conducted at Marseille University Hospitals\u2019 Ophthalmology departments between December 2015 and December 2021. All patients with papilloedema resulting from elevated intracranial hypertension at the initial presentation were included. Ophthalmological evaluations included analysing retinal nerve fibre layer (RNFL), ganglion cell layer (GCL) and total peripapillary retinal thickness (RT).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The study included 222 eyes from 113 patients. The main aetiologies of intracranial hypertension were idiopathic intracranial hypertension (49\/113), intracranial tumours (33\/113) and cerebral venous thrombosis (15\/113). The initial RNFL and RT showed significant correlations with optic atrophy. The mean RNFL was 199.63\u2009\u00b5m in the \u2018no atrophy\u2019 group and 365.28\u2009\u00b5m in the \u2018atrophy\u2019 group (p&lt;0.001). Similarly, the mean RT was 483.72\u2009\u00b5m in the \u2018non-atrophy\u2019 group and 796.69\u2009\u00b5m in the \u2018atrophy\u2019 group (p&lt;0.001). The presence of peripapillary haemorrhages showed a strong correlated with optic atrophy with an OR=19.12 (p&lt;0.001). Impaired initial visual acuity was also associated with final optic atrophy with an OR=7.76 (p=0.020). Furthermore, impaired initial GCL was a major predictor of optic atrophy (OR=18.25 (p=0.021)).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our study highlights the risk factors for optic atrophy in papilloedema, aiming to facilitate the early detection of patients at a high risk of vision loss and enable more aggressive medical or surgical management.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjophth-2023-001375","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:05:43Z","timestamp":1699362343000},"page":"e001375","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":8,"title":["Risk factors associated with progression from papilloedema to optic atrophy: results from a cohort of 113 patients"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6882-7555","authenticated-orcid":false,"given":"Ruben","family":"Attia","sequence":"first","affiliation":[{"name":"Ophthalmology, Hospital Timone, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Fitoussi","sequence":"additional","affiliation":[{"name":"Ophthalmology, Hospital Timone, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Mairot","sequence":"additional","affiliation":[{"name":"Ophthalmology, Hospital Timone, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Demortiere","sequence":"additional","affiliation":[{"name":"Neurology, Hospital Timone, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Patrick","family":"Stellman","sequence":"additional","affiliation":[{"name":"Neuroimaging service, CRMBM, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Penelope","family":"Tilsley","sequence":"additional","affiliation":[{"name":"Neuroimaging service, CRMBM, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bertrand","family":"Audoin","sequence":"additional","affiliation":[{"name":"Neurology, Hospital Timone, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7192-1523","authenticated-orcid":false,"given":"Thierry","family":"David","sequence":"additional","affiliation":[{"name":"Ophthalmology, Hospital Timone, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natacha","family":"Stolowy","sequence":"additional","affiliation":[{"name":"Ophthalmology, Hospital Timone, Marseille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.1","DOI":"10.1001\/archneur.1982.00510200003001"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.2","DOI":"10.1016\/j.ophtha.2017.01.006"},{"key":"2025090109220402000_8.1.e001375.3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.ncl.2021.11.011","article-title":"Current indications for management options in pseudotumor cerebri","volume":"40","author":"Akhter","year":"2022","journal-title":"Neurol Clin"},{"key":"2025090109220402000_8.1.e001375.4","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.1016\/j.wneu.2018.09.070","article-title":"Endovascular treatment for venous sinus stenosis in idiopathic intracranial hypertension: an observational study of clinical indications, surgical technique, and long-term outcomes","volume":"121","author":"Shields","year":"2019","journal-title":"World Neurosurg"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.5","DOI":"10.1136\/jnnp.45.1.13"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.6","DOI":"10.1001\/archophthalmol.2010.94"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.7","DOI":"10.1016\/S0161-6420(84)34149-5"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.8","DOI":"10.1167\/iovs.12-9438"},{"key":"2025090109220402000_8.1.e001375.9","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.9.3.24","article-title":"Optic nerve head volumetry by optical coherence tomography in papilledema related to idiopathic intracranial hypertension","volume":"9","author":"Dreesbach","year":"2020","journal-title":"Transl Vis Sci Technol"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.10","DOI":"10.1212\/WNL.0b013e3182a55f17"},{"key":"2025090109220402000_8.1.e001375.11","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1007\/s00415-017-8532-x","article-title":"Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension","volume":"264","author":"Albrecht","year":"2017","journal-title":"J Neurol"},{"key":"2025090109220402000_8.1.e001375.12","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10792-021-01711-6","article-title":"Management of the regression of papilledema with regional axon loss in idiopathic intracranial hypertension patients","volume":"41","author":"Kabatas","year":"2021","journal-title":"Int Ophthalmol"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.13","DOI":"10.1093\/brain\/97.1.313"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.14","DOI":"10.1136\/bjophthalmol-2015-307043"},{"key":"2025090109220402000_8.1.e001375.15","first-page":"91","article-title":"Correlation between retinal nerve fiber layer thickness by optical coherence tomography and perimetric parameters in optic atrophy","volume":"3","author":"Soltan-Sanjari","year":"2008","journal-title":"J Ophthalmic Vis Res"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.16","DOI":"10.1016\/S1474-4422(15)00298-7"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.17","DOI":"10.1016\/j.preteyeres.2015.10.001"},{"key":"2025090109220402000_8.1.e001375.18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4103\/tjo.tjo_44_20","article-title":"Clinical and demographic differences between idiopathic intracranial hypertension patients with mild and severe papilledema","volume":"11","author":"Micieli","year":"2021","journal-title":"Taiwan J Ophthalmol"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.19","DOI":"10.1097\/WNO.0b013e31823f852d"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.20","DOI":"10.1097\/WNO.0000000000000205"},{"key":"2025090109220402000_8.1.e001375.21","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1007\/s10072-013-1373-1","article-title":"Quantitative analysis of optic nerve damage in idiopathic intracranial hypertension (IIH) at diagnosis","volume":"34 Suppl 1","author":"Marzoli","year":"2013","journal-title":"Neurol Sci"},{"key":"2025090109220402000_8.1.e001375.22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/01658107.2018.1476558","article-title":"Ganglion cell complex analysis as a potential indicator of early neuronal loss in idiopathic intracranial hypertension","volume":"43","author":"Athappilly","year":"2019","journal-title":"Neuroophthalmology"},{"key":"2025090109220402000_8.1.e001375.23","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1212\/CON.0000000000000770","article-title":"Idiopathic intracranial hypertension","volume":"25","author":"Thurtell","year":"2019","journal-title":"CONTINUUM (Minneap Minn)"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.24","DOI":"10.1177\/1747493015620708"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.25","DOI":"10.1212\/01.wnl.0000333254.84120.f5"},{"key":"2025090109220402000_8.1.e001375.26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0036965","article-title":"Optic nerve head quantification in idiopathic intracranial hypertension by spectral domain OCT","volume":"7","author":"Kaufhold","year":"2012","journal-title":"PLoS One"},{"doi-asserted-by":"publisher","key":"2025090109220402000_8.1.e001375.27","DOI":"10.1007\/s00417-012-2039-z"},{"key":"2025090109220402000_8.1.e001375.28","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00798","article-title":"Methods for quantifying optic disc volume and peripapillary deflection volume using radial optical coherence tomography scans and association with intracranial pressure","volume":"10","author":"Patel","year":"2019","journal-title":"Front Neurol"}],"container-title":["BMJ Open Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjophth-2023-001375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T16:22:14Z","timestamp":1756743734000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjophth.bmj.com\/lookup\/doi\/10.1136\/bmjophth-2023-001375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,11,7]]},"published-print":{"date-parts":[[2023,11]]}},"alternative-id":["10.1136\/bmjophth-2023-001375"],"URL":"https:\/\/doi.org\/10.1136\/bmjophth-2023-001375","relation":{},"ISSN":["2397-3269"],"issn-type":[{"type":"electronic","value":"2397-3269"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}